Romiplostim 250mcg injection

Romiplostim 250mcg injection is a prescription hematology medicine belonging to the class of thrombopoietin receptor agonists. It is primarily used in specialized treatment protocols to help support platelet production in patients with low platelet counts. This injectable medicine is supplied exclusively for clinical and hospital use under strict medical supervision.

Romiplostim works by stimulating platelet production in the bone marrow, assisting in maintaining safe platelet levels for patients under prescribed hematology treatment plans. Its injectable formulation ensures precise and controlled dosing, making it suitable for administration by qualified healthcare professionals. Romiplostim 250 mcg injection should always be used according to approved clinical guidelines.

Romiplostim 250mcg Injection is a trusted hematology product commonly supplied to hospitals, clinics, and licensed healthcare providers. This product is suitable for regulated domestic and international pharmaceutical markets and is available only on prescription. The Romiplostim 250 mcg injection product ensures consistent quality and reliable performance in platelet support therapy.

Product Features

• Contains Romiplostim as the active ingredient
• Injectable formulation for hospital use
• 250 mcg dosage strength
• Used in hematology and specialty care
• Prepared according to pharmaceutical quality standards
• Suitable for institutional and regulated export supply

How It Helps

• Supports platelet production in patients with low counts
• Helps maintain safe platelet levels for treatment
• Assists in specialized hematology care protocols
• Ensures controlled and reliable injectable therapy